Seeking Alpha

Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders....

Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders. The company says that based on the results it has pushed forward with applications to the FDA and EU to expand the range of patients approved for the medication.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)